echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Jining implements the centralized drug procurement policy

    Jining implements the centralized drug procurement policy

    • Last Update: 2021-02-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Jining City has actively implemented the centralized procurement policy of medicines, and the 57 drugs selected have been purchased and used in various public medical institutions at all levels, effectively reducing the burden on the medical expenses of the masses.In December 2019, the state launched the first batch of centralized procurement of drugs, the 25 drugs selected for the treatment of chronic diseases such as fat reduction, blood pressure, antiviral, anti-tumor. At present, all 25 kinds of drugs are purchased and used in various public medical institutions at all levels in Jining City according to the selected price, and the selected price has decreased by an average of 59% compared with the lowest purchase price of the same drug in the expanded area in 2018.In April this year, Jining City on time to implement the country's second batch of drug centralized procurement policy, from sugar-reducing heat-reducing and other commonly used drugs to expensive anti-cancer drugs, 32 selected drugs covering a number of therapeutic areas, some of the decline of 95.9%.It is understood that the third batch of centralized procurement of 55 kinds of drugs, covering high blood pressure, diabetes, cancer disease, mental illness, anti-infection and other therapeutic areas, the results of the election will be fully implemented in Jining City on November 16. At the same time, Jining City actively promote the implementation of cross-city joint procurement with Linyi, Zhanzhuang and Luze and other places, the establishment of the "Lunan Economic Circle public medical institutions drug (supplies) procurement alliance", to further reduce the public medical institutions drug supplies transaction costs and procurement prices, reduce the burden of medical treatment of the masses. (
    mass network
    )
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.